Fatal evolution of Chagas'disease/Aids co-infection: diagnostic difficulties between myocarditis reactivation and chronic chagasic myocardiopathy

被引:15
作者
de Almeida, Eros Antonio [1 ]
Silva, Eliane Lages [2 ]
Guariento, Maria Elena [1 ]
de Souza, Milton Lopes [1 ]
Aoki, Francisco Hideo [1 ]
Pedro, Rogerio de Jesus [1 ]
机构
[1] Univ Estadual Campinas, Fac Ciencias Med, Dept Clin Med, BR-13083970 Campinas, SP, Brazil
[2] Univ Fed Triangulo Mineiro, Disciplina Parasitol, Uberaba, MG, Brazil
关键词
Chagas; Trypanosomiasis; Acquired immunodeficiency; Reactivation; Coinfection; DISEASE AMERICAN TRYPANOSOMIASIS; AIDS;
D O I
10.1590/S0037-86822009000200021
中图分类号
R38 [医学寄生虫学]; Q [生物科学];
学科分类号
07 ; 0710 ; 09 ; 100103 ;
摘要
Chagas disease is a type of parasitosis caused by the protozoan Trypanosoma cruzi, and it is transmitted by triatomine insects. This disease is found between the southern United States to Argentina and approximately 14 million people in Latin America are believed to be infected, predominantly with the chronic form of the disease. Reactivation of Chagas disease can occur among immunosuppressed patients, as has been observed among AIDS patients. In one such case, we observed cardiac decompensation with severe ventricular dysfunction and arrhythmias. This case was thought to be reactivation of Chagas disease in the myocardium, since the xenodiagnosis was positive. Specific treatment for Trypanosoma cruzi was administered, consisting of benznidazole, but the course of treatment was not completed because the patient died due to cardiopathic complications. The necropsy showed the usual stigmas of chronic Chagas cardiopathy, such as fibrosing myocarditis and a decreased number of neurons in the digestive system. There were no amastigote forms of Trypanosoma cruzi in any of the tissue samples studied. Therefore, reactivation of Chagas disease was not demonstrated but, rather, the natural evolution of chronic Chagas cardiopathy was demonstrated.
引用
收藏
页码:199 / 202
页数:4
相关论文
共 14 条
[1]  
CanalEnergia, 2020, CUSTO BRASIL INVIABI
[2]   Toxic side effects of drugs used to treat Chagas' disease (American trypanosomiasis) [J].
Castro, Jose A. ;
de Mecca, Maria Montalto ;
Bartel, Laura C. .
HUMAN & EXPERIMENTAL TOXICOLOGY, 2006, 25 (08) :471-479
[3]   Reactivation of Chagas disease with central nervous system involvement in HIV-infected patients in Argentina, 1992-2007 [J].
Cordova, Ezequiel ;
Boschi, Analia ;
Ambrosioni, Juan ;
Cudos, Carolina ;
Corti, Marcelo .
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2008, 12 (06) :587-592
[4]   AIDS and Chagas' disease [J].
Corti, M .
AIDS PATIENT CARE AND STDS, 2000, 14 (11) :581-588
[5]  
Santos Eder de Oliveira, 2002, Braz J Infect Dis, V6, P317, DOI 10.1590/S1413-86702002000600009
[6]   AIDS AND CHAGAS-DISEASE WITH CENTRAL-NERVOUS-SYSTEM TUMOR-LIKE LESION [J].
DELCASTILLO, M ;
MENDOZA, G ;
OVIEDO, J ;
BIANCO, RPP ;
ANSELMO, AE ;
SILVA, M .
AMERICAN JOURNAL OF MEDICINE, 1990, 88 (06) :693-694
[7]  
Ferreira M. S., 1997, CLIN TERAPEUTICA DOE, P365
[8]  
Pereira J B, 1989, Rev Soc Bras Med Trop, V22, P39
[9]  
Rassi A, 2000, CLIN CARDIOL, V23, P883, DOI 10.1002/clc.4960231205
[10]   Manifestations of Chagas disease (American trypanosomiasis) in patients with HIVAIDS [J].
Sartori, A. M. C. ;
Ibrahim, K. Y. ;
Westphalen, E. V. Nunes ;
Braz, L. M. A. ;
Oliveira, O. C., Jr. ;
Gakiyat, E. ;
Lopes, M. H. ;
Shikanai-Yasuda, M. A. .
ANNALS OF TROPICAL MEDICINE AND PARASITOLOGY, 2007, 101 (01) :31-50